We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+33.36%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.6B
AUM Growth
+$6.01B
Cap. Flow
-$1.19B
Cap. Flow %
-4.17%
Top 10 Hldgs %
11.57%
Holding
713
New
83
Increased
216
Reduced
260
Closed
78

Top Sells

Rank Stock Value
1
SHOP icon
Shopify
SHOP
+$122M
2
BABA icon
Alibaba
BABA
+$107M
3
DGX icon
Quest Diagnostics
DGX
+$107M
4
PFE icon
Pfizer
PFE
+$88.9M
5
DIS icon
Walt Disney
DIS
+$88.3M

Sector Composition

Rank Sector Weight
1 Technology 19.95%
2 Healthcare 14.63%
3 Consumer Discretionary 11.99%
4 Financials 11.51%
5 Industrials 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOOR
376
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$15.6M 0.05%
200,145
-18,300
-8% -$1.11M
SBAC icon
377
SBA Communications
SBAC
$19.3B
$15.2M 0.05%
51,010
-16,637
-25% -$4.91M
CALX icon
378
Calix
CALX
$2.22B
$15.1M 0.05%
1,013,680
-407,543
-29% -$4.68M
PARR icon
379
Par Pacific Holdings
PARR
$4.31B
$15M 0.05%
1,664,460
+532,154
+47% +$4.58M
AAMI
380
Acadian Asset Management
AAMI
$2.99B
$14.9M 0.05%
1,195,758
-103,200
-8% -$845K
MTZ icon
381
MasTec
MTZ
$25.6B
$14.8M 0.05%
330,776
-21,135
-6% -$801K
BABA icon
382
Alibaba
BABA
$279B
$14.8M 0.05%
68,640
-515,419
-88% -$107M
CHRS icon
383
Coherus Oncology
CHRS
$227M
$14.6M 0.05%
816,768
-125,013
-13% -$2.12M
SJM icon
384
J.M. Smucker
SJM
$13.1B
$14.4M 0.05%
136,411
-5,095
-4% -$573K
DD icon
385
DuPont de Nemours
DD
$18.7B
$14.3M 0.05%
215,137
+79,785
+59% +$4.66M
GWPH
386
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$14.3M 0.05%
116,845
-7,410
-6% -$841K
TWST icon
387
Twist Bioscience
TWST
$5.69B
$14.3M 0.05%
314,842
-36,887
-10% -$1.32M
HI
388
DELISTED
Hillenbrand
HI
$14M 0.05%
515,557
-32,681
-6% -$742K
CMCO icon
389
Columbus McKinnon
CMCO
$596M
$13.8M 0.05%
411,238
-59,500
-13% -$1.64M
WFC icon
390
Wells Fargo
WFC
$258B
$13.7M 0.05%
534,564
-1,605,245
-75% -$43.9M
FOUR icon
391
Shift4
FOUR
$4.26B
$13.6M 0.05%
+383,690
New +$14M
NTRS icon
392
Northern Trust
NTRS
$22.4B
$13.5M 0.05%
170,400
-434,500
-72% -$34.5M
SILK
393
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$13.5M 0.05%
321,197
+11,649
+4% +$447K
GPN icon
394
Global Payments
GPN
$23.8B
$13.4M 0.05%
79,287
-65,293
-45% -$10.9M
SLAB icon
395
Silicon Laboratories
SLAB
$7.15B
$13.1M 0.05%
130,276
-8,372
-6% -$782K
BRO icon
396
Brown & Brown
BRO
$23.7B
$12.7M 0.04%
312,559
-3,450
-1% -$133K
CHD icon
397
Church & Dwight Co
CHD
$23.1B
$12.7M 0.04%
164,423
-555,187
-77% -$40.4M
MO icon
398
Altria Group
MO
$113B
$12.6M 0.04%
320,956
+167,462
+109% +$6.53M
ALG icon
399
Alamo Group
ALG
$1.92B
$12.6M 0.04%
122,330
-13,500
-10% -$1.3M
WIX icon
400
WIX.com
WIX
$2.37B
$12.6M 0.04%
49,003
-2,655
-5% -$471K

Similar funds

Lord, Abbett & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Lord, Abbett & Co held 713 positions worth $28.6B, up 27% from $22.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Lord, Abbett & Co withdrew a net $1.19B in Q2 2020, closing 78 positions and reducing 260 holdings. Its most notable exit was Raytheon Company, an estimated $87.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lord, Abbett & Co opened a new position in Immunomedics Inc worth $117M.

  • Lord, Abbett & Co's largest Q2 2020 buy was Immunomedics Inc: 3,306,343 shares worth $117M.
  • Lord, Abbett & Co added most to Texas Instruments in Q2 2020, an estimated $99.4M increase.
  • Lord, Abbett & Co's biggest Q2 2020 reduction was Shopify, cutting an estimated $122M.
  • Lord, Abbett & Co fully exited Raytheon Company in Q2 2020, selling an estimated $87.9M.
  • Lord, Abbett & Co's ten largest holdings make up 12% of its $28.6B portfolio in Q2 2020.
  • Lord, Abbett & Co opened 83 new positions and closed 78 in Q2 2020.
  • Lord, Abbett & Co's portfolio value rose 27% quarter-over-quarter to $28.6B.

Based on Lord, Abbett & Co's 13F filing for Q2 2020, filed 14 Aug 2020.